Besides, BCAR1 is known as Src substrate, and Src inhibitor AZD0530 can also result in significant inhibition of cell migration and matrigel invasion in lung cancer cells [21], which potentially supports the carcinogenesis of Src/BCAR1 axis. Here, SRC is linked to lung carcinoma.